Report

Global Cholera Vaccines Market Size study & Forecast, by Vaccine Type (Whole cell V. cholerae O1 with Recombinant B-subunit, and Killed Oral O1, and O139), by Product (Vaxchora, Dukoral, Shanchol and Other Products) and Regional Analysis, 2022-2029

  • Publish Date: Feb,2023
  • Report ID: 3-2-1746
  • Page : 200
  • Report Type : PDF (Email)
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. Cholera Vaccine Market, by Region, 2019-2029 (USD Million)
1.2.2. Cholera Vaccine Market, by Vaccine Type, 2019-2029 (USD Million)
1.2.3. Cholera Vaccine Market, by Product, 2019-2029 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cholera Vaccine Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cholera Vaccine Market Dynamics
3.1. Cholera Vaccine Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. High incidence of cholera
3.1.1.2. Rise in the number of initiatives to control cholera
3.1.2. Market Challenges
3.1.2.1. Adverse effects of vaccines
3.1.3. Market Opportunities
3.1.3.1. Rising awareness about cholera preventive care
3.1.3.2. Rise in cholera vaccines across the world
Chapter 4. Global Cholera Vaccine Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Cholera Vaccine Market, by Vaccine Type
6.1. Market Snapshot
6.2. Global Cholera Vaccine Market by Vaccine Type, Performance - Potential Analysis
6.3. Global Cholera Vaccine Market Estimates & Forecasts by Vaccine Type 2019-2029 (USD Million)
6.4. Cholera Vaccine Market, Sub Segment Analysis
6.4.1. Whole cell V. cholerae O1 with Recombinant B-subunit
6.4.2. Killed Oral O1 and O139
Chapter 7. Global Cholera Vaccine Market, by Product
7.1. Market Snapshot
7.2. Global Cholera Vaccine Market by Product, Performance - Potential Analysis
7.3. Global Cholera Vaccine Market Estimates & Forecasts by Product 2019-2029 (USD Million)
7.4. Cholera Vaccine Market, Sub Segment Analysis
7.4.1. Vaxchora
7.4.2. Dukoral
7.4.3. Shanchol
7.4.4. Other Products
Chapter 8. Global Cholera Vaccine Market, Regional Analysis
8.1. Cholera Vaccine Market, Regional Market Snapshot
8.2. North America Cholera Vaccine Market
8.2.1. U.S. Cholera Vaccine Market
8.2.1.1. Vaccine Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. Product breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Cholera Vaccine Market
8.3. Europe Cholera Vaccine Market Snapshot
8.3.1. U.K. Cholera Vaccine Market
8.3.2. Germany Cholera Vaccine Market
8.3.3. France Cholera Vaccine Market
8.3.4. Spain Cholera Vaccine Market
8.3.5. Italy Cholera Vaccine Market
8.3.6. Rest of Europe Cholera Vaccine Market
8.4. Asia-Pacific Cholera Vaccine Market Snapshot
8.4.1. China Cholera Vaccine Market
8.4.2. India Cholera Vaccine Market
8.4.3. Japan Cholera Vaccine Market
8.4.4. Australia Cholera Vaccine Market
8.4.5. South Korea Cholera Vaccine Market
8.4.6. Rest of Asia Pacific Cholera Vaccine Market
8.5. Latin America Cholera Vaccine Market Snapshot
8.5.1. Brazil Cholera Vaccine Market
8.5.2. Mexico Cholera Vaccine Market
8.5.3. Rest of Latin America Cholera Vaccine Market
8.6. Rest of The World Cholera Vaccine Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Mitsubishi Tanabe Pharma Corporation
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Takeda Pharmaceutical Co., Ltd.
9.2.3. AstraZeneca
9.2.4. GlaxoSmithKline plc (GSK)
9.2.5. Shantha Biotechnics Private Limited
9.2.6. Valneva SE
9.2.7. Astellas Pharma, Inc.
9.2.8. Emergent BioSolutions, Inc.
9.2.9. Pfizer, Inc.
9.2.10. Merck & Co., Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption